PetLife Pharmaceuticals, Inc. 10-K, filed Dec 21, 2016: IDEA: XBRL DOCUMENT
Income Taxes (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Provision for Refundable Federal Income Tax |
The provision for refundable federal income tax consists of the following for the years ending:
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Deferred Tax Asset |
The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||